Identical genetic control of MLC reactivity to different MHC incompatibilities, independent of production of and response to IL-2
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
8613140
DOI
10.1007/bf02602654
Knihovny.cz E-zdroje
- MeSH
- aktivace lymfocytů * MeSH
- antigeny CD3 imunologie MeSH
- CD4-pozitivní T-lymfocyty imunologie MeSH
- CD8-pozitivní T-lymfocyty imunologie MeSH
- hlavní histokompatibilní komplex MeSH
- interferon gama fyziologie MeSH
- interleukin-10 fyziologie MeSH
- interleukin-2 farmakologie MeSH
- kultivované buňky MeSH
- myši inbrední BALB C MeSH
- myši MeSH
- slezina cytologie MeSH
- T-lymfocyty - podskupiny imunologie MeSH
- test smíšené lymfocytární kultury MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- antigeny CD3 MeSH
- interferon gama MeSH
- interleukin-10 MeSH
- interleukin-2 MeSH
The inbred strain STS/A exhibits a higher proliferative response in the mixed lymphocyte culture (MLC) to stimulator cells of all 11 tested inbred mouse strains with 10 different major histocompatibility complex (MHC) haplotypes, as well as to stimulation with IL-2 than does the strain BALB/cHeA. However, alloantigen-stimulated BALB/c cells produce more IL-2 than STS/A cells. To study the genetic basis of these differences, we used 20 recombinant congenic strains (RCS) of the CcS/Dem series. Each of these CcS/Dem RC strains contains a different subset of about 12.5% of genes from the STS/A strain and the remaining approximately 87.5% of BALB/c origin genes. As a result the multiple non-linked genes responsible for phenotypic differences between BALB/c and STS/A became separated into different CcS/Dem strains. The strain distribution pattern (SD) of high or low MLC response of individual CcS/Dem strains to stimulator cells of four different strains was almost identical, indicating that differences in responsiveness, rather than the alloantigenic difference itself, determine the magnitude of the response, and that the responsiveness to different alloantigens is largely controlled by the same genes. The SDP of IL-2 stimulation was different from that of MLC responsiveness. The differences in the proliferative responses observed among individual CcS/Dem strains were not due to differences in numbers of CD3+, CD4+ or CD8+ cells or to the observed differences in IL-2 production, and hence they likely reflect genetically determined intrinsic properties of T cells. These results show that a set of non-linked genes controls proliferative responses in MLC irrespective of the MHC haplotype of the stimulator cells, and that stimulation with IL-2 and production of IL-2 are controlled by different subsets of genes. Since the genomes of all RCS are extensively characterized by microsatellite markers, they can be used to map the genes controlling proliferative responsiveness to stimulation with alloantigens and IL-2.
Zobrazit více v PubMed
Immunogenetics. 1988;28(6):455-8 PubMed
J Immunol. 1978 Jun;120(6):2027-32 PubMed
J Exp Med. 1988 Aug 1;168(2):795-800 PubMed
Mamm Genome. 1991;1(4):217-27 PubMed
Immunogenetics. 1995;41(5):301-11 PubMed
Nature. 1985 May 23-29;315(6017):333-6 PubMed
Int Immunol. 1992 Dec;4(12):1389-97 PubMed
J Immunol. 1990 Nov 1;145(9):2938-45 PubMed
J Immunol. 1988 Nov 1;141(9):2907-11 PubMed
Transplantation. 1992 Dec;54(6):1071-8 PubMed
Genomics. 1995 Feb 10;25(3):609-14 PubMed
Transplantation. 1993 May;55(5):1159-66 PubMed
Transplantation. 1994 Jun 15;57(11):1638-42 PubMed
Immunogenetics. 1986;24(6):416-22 PubMed
J Immunol. 1988 Feb 15;140(4):1148-52 PubMed
Cell. 1993 Apr 9;73(1):5-8 PubMed
Immunol Rev. 1983;74:29-56 PubMed
Transplant Rev. 1972;12:91-140 PubMed
Nature. 1985 Mar 7-13;314(6006):98-100 PubMed
Immunogenetics. 1980;10(6):545-55 PubMed
Mamm Genome. 1994 Mar;5(3):174-6 PubMed
Oncogene. 1992 Mar;7(3):563-6 PubMed
Eur J Immunol. 1973 Oct;3(10):645-9 PubMed
J Immunol. 1987 Jun 15;138(12):4175-9 PubMed
J Immunol. 1986 Apr 1;136(7):2348-57 PubMed
Cell. 1989 May 19;57(4):521-4 PubMed
Proc Natl Acad Sci U S A. 1978 Jun;75(6):2844-8 PubMed
Biomedicine. 1973 Sep;18(5):401-7 PubMed
Eur J Immunol. 1979 Nov;9(11):875-86 PubMed
Lab Anim. 1988 Jan;22(1):61-6 PubMed
FASEB J. 1992 Jul;6(10):2826-35 PubMed
Science. 1970 Jun 5;168(3936):1170-9 PubMed
Genomics. 1995 Dec 10;30(3):553-7 PubMed
Gene-specific sex effects on eosinophil infiltration in leishmaniasis
Genetic control of T-cell proliferative response in mice linked to chromosomes 11 and 15